秘密研究所

If you need help accessing our website, call 855-698-9991
秘密研究所 Langone Provider

Mila B. Ortigoza, MD, PhD

秘密研究所 Langone Provider
  • Specialty: Infectious Diseases
  • Treats: Adults
  • Language: English
  • Phone: 646-501-9831
View Locations

As an internal medicine and infectious disease specialist at 秘密研究所 Langone and 秘密研究所 Grossman School of Medicine, I am dedicated to improving patient outcomes through high-quality care and patient satisfaction. My approach emphasizes proactive healthcare engagement, ensuring that my patients are well-informed and actively involved in their treatment plans.

I specialize in managing patients with both general and complex infectious disease conditions, with a particular focus on respiratory viruses of pandemic potential. My extensive experience in this field allows me to provide expert care for patients dealing with challenging infections, ensuring they receive the most effective and up-to-date treatments available.

With more than 20 years of experience, I bring a wealth of knowledge and expertise to my practice. My work as a physician-scientist involves leading a basic and translational research program aimed at advancing our understanding of the biology of respiratory viruses. I have developed new models to study the pathogenesis and host-to-host transmission of influenza viruses, with the ultimate goal of creating innovative approaches to prevent and stop their spread.

My journey into medicine was inspired by a deep-seated passion for science and a desire to make a meaningful impact on public health. I pursued both an MD and PhD degree to combine clinical practice with research, allowing me to contribute to the advancement of medical knowledge while providing exceptional care to my patients. At 秘密研究所 Langone, I am proud to be part of a team that values coordinated care, ensuring the best possible outcomes for those we serve.

Positions
  • Assistant Professor,
  • Assistant Professor,
Board Certifications
  • American Board of Internal Medicine (Infectious Disease), 2022
  • American Board of Internal Medicine - Internal Medicine, 2020
Education and Training
  • Fellowship, 秘密研究所 Grossman School of Medicine, Infectious Disease, 2017
  • Residency, 秘密研究所 Grossman School of Medicine, Internal Medicine, 2015
  • MD from Mount Sinai School of Medicine, 2013
  • PhD from Mount Sinai School of Medicine, 2011

Is this your profile?

This provider accepts the following insurance plans.

View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Mila B. Ortigoza, MD, PhD does not accept insurance.

Locations and Appointments

秘密研究所 Langone Infectious Disease Associates

530 1st Avenue, Suite 7F, New York, NY 10016

Phone

646-501-9831

Fax

646-501-2027

Interests

Influenza, SARS-CoV-2, transmission and pathogenesis of respiratory viruses, therapeutics and vaccines

Research Summary
My research laboratory is at the forefront of pandemic preparedness, focusing on understanding the transmission dynamics of respiratory viruses with pandemic potential and developing novel strategies to halt their spread. We have pioneered and optimized several mouse models to study host-to-host  respiratory transmission of influenza virus, SARS-CoV-2, and bacterial pathogens. This approach enables a comprehensive examination of transmission biology from both pathogen and host perspectives. In addition to our advanced mouse models, we specialize in using primary human cells and tissue models to complement our animal studies, ensuring clinical relevance and applicability to human health. Our integrated research approach aims to bridge the gap between experimental findings and real-world implications, ultimately contributing to the development of effective interventions for pandemic prevention and control.
  Our research is driven by two fundamental questions: 1. What factors make a host infectious? 2. What determines host susceptibility to infections?
By addressing these pivotal questions, we aim to develop effective broad-spectrum mucosal vaccines and antiviral therapies that target critical stages of transmission. Our ultimate goal is to contain the spread and mitigate the impact of pandemic influenza and other respiratory diseases through scientifically rigorous and impactful interventions. Our work is designed to advance public health preparedness and response, ensuring robust defenses against future pandemics.

  • Montgomery, Matthew T; Ortigoza, Mila; Loomis, Cynthia; Weiser, Jeffrey N

    MBio. 2024 Dec 11; e0257924

  • Gray-Gaillard, Sophie L; Solis, Sabrina M; Chen, Han M; Monteiro, Clarice; Ciabattoni, Grace; Samanovic, Marie I; Cornelius, Amber R; Williams, Tijaana; Geesey, Emilie; Rodriguez, Miguel; Ortigoza, Mila Brum; Ivanova, Ellie N; Koralov, Sergei B; Mulligan, Mark J; Herati, Ramin Sedaghat

    Science immunology. 2024 Jun 21; 9(96):eadj8526

  • Frontera, Jennifer A; Betensky, Rebecca A; Pirofski, Liise-Anne; Wisniewski, Thomas; Yoon, Hyunah; Ortigoza, Mila B

    Neurology neuroimmunology & neuroinflammation. 2024 May ; 11(3):e200227

Related News